Slide 1: Q4 2023 Financial Results
Q4 2023 Financial Results March 28, 2024 1 © 2024 Forian Inc. All Rights Reserved.
Slide 2: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In
Slide 3: Slide 3
Slide 4: Revenue and Adjusted EBITDA
Revenue and Adjusted EBITDA Q4 2023 YTD Q4 2023 Period-over- Period-over- 2023 2022 Period % 2023 2022 Period % Unaudited Unaudited Change Unaudited Unaudited Change Total revenue $ 5,369 $ 4,970 8% $ 20,481 $ 16,418 25% (Loss) Income from continuing operations, net of tax $ (381) $ (1,900) 80% $ 1,
Slide 5: Revenue Trend
Revenue Trend • 8% Q4 2023 revenue growth over same quarter last year • 25% Q4 2023 revenue growth over same period YTD last year 5 © 2024 Forian Inc. All Rights Reserved.
Slide 6: Costs and Expenses
Costs and Expenses Focused business model drives cost reductions in other costs and expenses: • 19% reduction in Q4 vs same QTR last Year • 23% reduction in full year 2023 vs prior year Note: Other costs and expenses excludes litigation costs, separation expenses, stock compensation and depreciation
Slide 7: Adjusted EBITDA
Adjusted EBITDA Continued improvement in Adjusted EBITDA driven by revenue growth and cost management Adjusted EBITDA is a non-U.S. GAAP measure. See Appendix for further information, including a reconciliation of Adjusted EBITDA to Net Loss. 7 © 2024 Forian Inc. All Rights Reserved.
Slide 8: Summary Balance Sheet Data $000's
Summary Balance Sheet Data $000’s 8 © 2024 Forian Inc. All Rights Reserved.
Slide 9: Full Year 2024 Outlook
Full Year 2024 Outlook Expect 2024 Healthcare Information Revenue growth of 5% to 15% Expect Adjusted EBITDA as a percentage of revenues (“EBITDA Margin”) of 8% to 12% in 2024 while continuing to expand information assets The outlook provided above constitutes forward-looking information within the
Slide 10: Q&A
Q&A 10 © 2024 Forian Inc. All Rights Reserved.
Slide 11: Appendix
Appendix 11 © 2024 Forian Inc. All Rights Reserved.
Slide 12: Reconciliation of U.S. GAAP to Non-GAAP Financial Measures
Reconciliation of U.S. GAAP to Non-GAAP Financial Measures This presentation includes a non-GAAP measure, which we define as financial information that has not been prepared in accordance with U.S. GAAP. The non-U.S. GAAP financial measure provided herein is earnings before interest, taxes, non-cash
Slide 13: Non-U.S. GAAP Reconciliations Reported Net Income to Adjusted EBITDA
Non-U.S. GAAP Reconciliations Reported Net Income to Adjusted EBITDA For the Three Months Ended For the Years Ended December 31, December 31, 2023 2022 2023 2022 Total revenues $ 5,368,932 $ 4,969,673 $ 20,481,330 $ 16,418,141 Net Income (loss) from continuing operations $ (381,014) $ (1,900,105) $
Slide 14: © 2024 Forian Inc. All Rights Reserved.
© 2024 Forian Inc. All Rights Reserved.